Near-infrared II fluorescence imaging of PD-L1 and VEGF for assessing and early prediction of “T+A” therapeutic responsiveness in hepatocellular carcinoma
Jukai Feng, Yuting Zhang, Wenhan Liu, Pu Zhang, Jianbin Xiao, Qiang Feng, Zhiyu Wang, Jinyu Zhang, Yang Zhong, Zhongying Shi, Meiqi Pan, Xiaolong Zhang, Jingfeng Liu, Jianmin Wang · 2026
Read Near-infrared II fluorescence imaging of PD-L1 and VEGF for assessing and early prediction of “T+A” therapeutic responsiveness in hepatocellular carcinoma by Jukai Feng, Yuting Zhang, Wenhan Liu, Pu Zhang, Jianbin Xiao, Qiang Feng, Zhiyu Wang, Jinyu Zhang, Yang Zhong, Zhongying Shi, Meiqi Pan, Xiaolong Zhang, Jingfeng Liu, Jianmin Wang (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13213648.txt.
Description
Jukai Feng and co-authors build glowing probes to predict liver cancer drug response in a 2026 paper. A paired drug combo is first choice for advanced liver cancer that cannot be cut out. No firm test shows who will gain from the pair. The team tags two tumor proteins with tiny glowing dots that shine in deep tissue light.
Each dot color tracks one protein, so both can be watched at once in mice. Glow strength matched lab measures of protein levels in tumors. Strong glow before treatment linked to better response to the drug pair. High glow also marked tumors with a muted immune setting and faster growth. The scan could guide personal drug choice without surgery.
Catalog record
| CREATOR | Jukai Feng, Yuting Zhang, Wenhan Liu, Pu Zhang, Jianbin Xiao, Qiang Feng, Zhiyu Wang, Jinyu Zhang, Yang Zhong, Zhongying Shi, Meiqi Pan, Xiaolong Zhang, Jingfeng Liu, Jianmin Wang |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 63 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |